GSK, Pfizer and Moderna face RSV vaccine sales slump
Pharma groups could see almost threefold drop in demand due to US health official decision, says Airfinity
Full Article
GSK, Pfizer and Moderna face RSV vaccine sales slump
FT.com
0 shares
1 views